Pharmacogenetic of propofol
- Conditions
- o medical condition or disease are investigated. This study will investigated the polymorfism in genes that are involved in the metabolism of a anastetic agent-propofol.
- Registration Number
- EUCTR2008-001309-40-SE
- Lead Sponsor
- inköping university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
ASA 1,healthy,caucasian patient undergoing surgery more that 30 min.
Elective surgery
Age 18-50 years
BMI 20-30
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Pregnacy
Acute surgery
Smokers
allergic to nuts
allergic to propofol
misuse of alcohol
not caucasian
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: To study the polymorfism of genes for the metabolism of propofol;Secondary Objective: ;Primary end point(s): There are no endpoint in this study. Please read the protocol:
- Secondary Outcome Measures
Name Time Method